rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2009-8-11
|
pubmed:abstractText |
Increasing long-term allograft survival is the main challenge in organ transplantation, and allograft loss due to chronic rejection has been found to correlate with episodes of early acute rejection. It is important to understand the mechanisms that maintain the donor-specific hyporesponsive state. This study prospectively evaluates immune events related to donor-specific hyporesponsiveness in the stable transplant patients on calcineurin inhibitors (CNIs).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Calcineurin,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclosporine,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/IL10 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/IL2RA protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-10,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2 Receptor alpha Subunit,
http://linkedlifedata.com/resource/pubmed/chemical/Mycophenolic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisolone,
http://linkedlifedata.com/resource/pubmed/chemical/Sirolimus,
http://linkedlifedata.com/resource/pubmed/chemical/Tacrolimus,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta,
http://linkedlifedata.com/resource/pubmed/chemical/everolimus,
http://linkedlifedata.com/resource/pubmed/chemical/mycophenolate mofetil
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1534-6080
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
88
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
435-41
|
pubmed:meshHeading |
pubmed-meshheading:19667950-Adult,
pubmed-meshheading:19667950-Calcineurin,
pubmed-meshheading:19667950-Cell Proliferation,
pubmed-meshheading:19667950-Cells, Cultured,
pubmed-meshheading:19667950-Cyclosporine,
pubmed-meshheading:19667950-Drug Therapy, Combination,
pubmed-meshheading:19667950-Enzyme Inhibitors,
pubmed-meshheading:19667950-Female,
pubmed-meshheading:19667950-Graft Survival,
pubmed-meshheading:19667950-Humans,
pubmed-meshheading:19667950-Immunosuppressive Agents,
pubmed-meshheading:19667950-Interleukin-10,
pubmed-meshheading:19667950-Interleukin-2 Receptor alpha Subunit,
pubmed-meshheading:19667950-Kidney Failure, Chronic,
pubmed-meshheading:19667950-Kidney Transplantation,
pubmed-meshheading:19667950-Lymphocyte Count,
pubmed-meshheading:19667950-Lymphocyte Culture Test, Mixed,
pubmed-meshheading:19667950-Male,
pubmed-meshheading:19667950-Middle Aged,
pubmed-meshheading:19667950-Mycophenolic Acid,
pubmed-meshheading:19667950-Prednisolone,
pubmed-meshheading:19667950-Prospective Studies,
pubmed-meshheading:19667950-Sirolimus,
pubmed-meshheading:19667950-T-Lymphocytes, Regulatory,
pubmed-meshheading:19667950-Tacrolimus,
pubmed-meshheading:19667950-Time Factors,
pubmed-meshheading:19667950-Transforming Growth Factor beta,
pubmed-meshheading:19667950-Transplantation Tolerance,
pubmed-meshheading:19667950-Up-Regulation,
pubmed-meshheading:19667950-Young Adult
|
pubmed:year |
2009
|
pubmed:articleTitle |
Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors.
|
pubmed:affiliation |
Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|